Hrt Financial LP I Teos Therapeutics, Inc. Transaction History
Hrt Financial LP
- $15.6 Billion
- Q1 2024
A detailed history of Hrt Financial LP transactions in I Teos Therapeutics, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 50,936 shares of ITOS stock, worth $714,122. This represents 0.0% of its overall portfolio holdings.
Number of Shares
50,936
Previous 58,616
13.1%
Holding current value
$714,122
Previous $641,000
8.27%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ITOS
# of Institutions
142Shares Held
30.2MCall Options Held
84.6KPut Options Held
32.2K-
Black Rock Inc. New York, NY4.11MShares$57.7 Million0.0% of portfolio
-
Mpm Asset Management LLC Cambridge, MA2.74MShares$38.4 Million15.24% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA2MShares$28 Million0.78% of portfolio
-
Boxer Capital, LLC San Diego, CA1.8MShares$25.3 Million1.28% of portfolio
-
Bio Impact Capital LLC Cambridge, MA1.75MShares$24.5 Million3.9% of portfolio
About iTeos Therapeutics, Inc.
- Ticker ITOS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 35,575,300
- Market Cap $499M
- Description
- Iteos Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of immuno-oncology therapeutics for patients. The company's product pipeline includes inupadenant, a small molecule antagonist of the adenosine A2AR antagonists that is in Phase 2 clinical trials; and EOS-448, an antagonist of TIGIT or ...